Silicon Laboratories (SLAB) to Release Quarterly Earnings on Wednesday

Silicon Laboratories (NASDAQ:SLAB - Get Free Report) is projected to post its Q2 2025 quarterly earnings results before the market opens on Wednesday, July 23rd. Analysts expect Silicon Laboratories to post earnings of $0.09 per share and revenue of $192.57 million for the quarter. Silicon Laboratories has set its Q2 2025 guidance at -0.010-0.190 EPS.

Silicon Laboratories (NASDAQ:SLAB - Get Free Report) last issued its earnings results on Tuesday, May 13th. The semiconductor company reported ($0.08) earnings per share for the quarter, topping the consensus estimate of ($0.09) by $0.01. Silicon Laboratories had a negative return on equity of 8.80% and a negative net margin of 25.16%. The business had revenue of $177.71 million for the quarter, compared to analyst estimates of $177.48 million. During the same period last year, the company posted ($0.92) EPS. The business's quarterly revenue was up 67.0% on a year-over-year basis. On average, analysts expect Silicon Laboratories to post $-1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Silicon Laboratories Trading Up 2.9%

NASDAQ:SLAB traded up $4.24 during mid-day trading on Friday, hitting $149.63. The company had a trading volume of 559,620 shares, compared to its average volume of 354,233. The business has a fifty day simple moving average of $136.58 and a 200-day simple moving average of $127.89. Silicon Laboratories has a 1 year low of $82.82 and a 1 year high of $160.00. The firm has a market capitalization of $4.87 billion, a price-to-earnings ratio of -29.28 and a beta of 1.47.

Insider Activity at Silicon Laboratories

In other news, CEO Robert Matthew Johnson sold 5,879 shares of Silicon Laboratories stock in a transaction dated Friday, May 16th. The shares were sold at an average price of $131.20, for a total value of $771,324.80. Following the completion of the transaction, the chief executive officer owned 73,688 shares of the company's stock, valued at $9,667,865.60. This trade represents a 7.39% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Christy Wyatt sold 546 shares of Silicon Laboratories stock in a transaction dated Tuesday, May 6th. The shares were sold at an average price of $104.45, for a total transaction of $57,029.70. Following the completion of the transaction, the director directly owned 8,492 shares of the company's stock, valued at approximately $886,989.40. This trade represents a 6.04% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 11,626 shares of company stock valued at $1,509,319. Corporate insiders own 1.60% of the company's stock.

Institutional Trading of Silicon Laboratories

Hedge funds and other institutional investors have recently bought and sold shares of the business. Jane Street Group LLC boosted its position in Silicon Laboratories by 329.2% in the first quarter. Jane Street Group LLC now owns 75,397 shares of the semiconductor company's stock valued at $8,487,000 after buying an additional 57,829 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in shares of Silicon Laboratories by 1.8% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 97,156 shares of the semiconductor company's stock worth $10,937,000 after buying an additional 1,679 shares during the last quarter. United Services Automobile Association bought a new stake in shares of Silicon Laboratories during the first quarter worth $235,000. Jones Financial Companies Lllp grew its stake in shares of Silicon Laboratories by 121.4% during the first quarter. Jones Financial Companies Lllp now owns 496 shares of the semiconductor company's stock worth $56,000 after buying an additional 272 shares during the last quarter. Finally, Millennium Management LLC grew its stake in shares of Silicon Laboratories by 2,804.1% during the first quarter. Millennium Management LLC now owns 99,842 shares of the semiconductor company's stock worth $11,239,000 after buying an additional 96,404 shares during the last quarter.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on the company. Benchmark reissued a "buy" rating and set a $160.00 target price on shares of Silicon Laboratories in a report on Tuesday, May 27th. Stifel Nicolaus lifted their price objective on shares of Silicon Laboratories from $144.00 to $160.00 and gave the stock a "buy" rating in a research report on Friday. KeyCorp upped their price objective on shares of Silicon Laboratories from $160.00 to $180.00 and gave the stock an "overweight" rating in a report on Tuesday, July 8th. Barclays cut their target price on shares of Silicon Laboratories from $120.00 to $80.00 and set an "equal weight" rating for the company in a research report on Tuesday, April 22nd. Finally, Wall Street Zen raised shares of Silicon Laboratories from a "sell" rating to a "hold" rating in a research report on Wednesday, May 14th. Four equities research analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to data from MarketBeat, Silicon Laboratories has an average rating of "Moderate Buy" and an average target price of $134.00.

Silicon Laboratories Company Profile

Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.